STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $23.93 billion. The enterprise value is $25.40 billion.
Important Dates
The last earnings date was Wednesday, February 4, 2026, after market close.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Feb 17, 2026 |
Share Statistics
STERIS has 98.15 million shares outstanding. The number of shares has decreased by -0.48% in one year.
| Current Share Class | 98.15M |
| Shares Outstanding | 98.15M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 95.48% |
| Float | 97.76M |
Valuation Ratios
The trailing PE ratio is 34.04 and the forward PE ratio is 22.32.
| PE Ratio | 34.04 |
| Forward PE | 22.32 |
| PS Ratio | 4.11 |
| Forward PS | 3.89 |
| PB Ratio | 3.34 |
| P/TBV Ratio | 19.23 |
| P/FCF Ratio | 26.09 |
| P/OCF Ratio | 18.89 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 16.24, with an EV/FCF ratio of 27.70.
| EV / Earnings | 35.89 |
| EV / Sales | 4.36 |
| EV / EBITDA | 16.24 |
| EV / EBIT | 23.28 |
| EV / FCF | 27.70 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.48 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 1.21 |
| Debt / FCF | 2.07 |
| Interest Coverage | 17.39 |
Financial Efficiency
Return on equity (ROE) is 10.47% and return on invested capital (ROIC) is 9.49%.
| Return on Equity (ROE) | 10.47% |
| Return on Assets (ROA) | 6.62% |
| Return on Invested Capital (ROIC) | 9.49% |
| Return on Capital Employed (ROCE) | 11.28% |
| Weighted Average Cost of Capital (WACC) | 9.44% |
| Revenue Per Employee | $327,656 |
| Profits Per Employee | $39,790 |
| Employee Count | 17,787 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 4.91 |
Taxes
In the past 12 months, STERIS has paid $228.45 million in taxes.
| Income Tax | 228.45M |
| Effective Tax Rate | 24.30% |
Stock Price Statistics
The stock price has increased by +11.13% in the last 52 weeks. The beta is 1.04, so STERIS's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +11.13% |
| 50-Day Moving Average | 259.07 |
| 200-Day Moving Average | 245.01 |
| Relative Strength Index (RSI) | 33.13 |
| Average Volume (20 Days) | 681,626 |
Short Selling Information
The latest short interest is 1.27 million, so 1.30% of the outstanding shares have been sold short.
| Short Interest | 1.27M |
| Short Previous Month | 1.37M |
| Short % of Shares Out | 1.30% |
| Short % of Float | 1.30% |
| Short Ratio (days to cover) | 2.48 |
Income Statement
In the last 12 months, STERIS had revenue of $5.83 billion and earned $707.74 million in profits. Earnings per share was $7.16.
| Revenue | 5.83B |
| Gross Profit | 2.58B |
| Operating Income | 1.09B |
| Pretax Income | 940.11M |
| Net Income | 707.74M |
| EBITDA | 1.56B |
| EBIT | 1.09B |
| Earnings Per Share (EPS) | $7.16 |
Full Income StatementBalance Sheet
The company has $423.70 million in cash and $1.90 billion in debt, with a net cash position of -$1.47 billion or -$15.03 per share.
| Cash & Cash Equivalents | 423.70M |
| Total Debt | 1.90B |
| Net Cash | -1.47B |
| Net Cash Per Share | -$15.03 |
| Equity (Book Value) | 7.17B |
| Book Value Per Share | 72.99 |
| Working Capital | 1.36B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.27 billion and capital expenditures -$349.69 million, giving a free cash flow of $917.10 million.
| Operating Cash Flow | 1.27B |
| Capital Expenditures | -349.69M |
| Free Cash Flow | 917.10M |
| FCF Per Share | $9.34 |
Full Cash Flow StatementMargins
Gross margin is 44.29%, with operating and profit margins of 18.72% and 12.14%.
| Gross Margin | 44.29% |
| Operating Margin | 18.72% |
| Pretax Margin | 16.13% |
| Profit Margin | 12.14% |
| EBITDA Margin | 26.84% |
| EBIT Margin | 18.72% |
| FCF Margin | 15.74% |
Dividends & Yields
This stock pays an annual dividend of $2.52, which amounts to a dividend yield of 1.03%.
| Dividend Per Share | $2.52 |
| Dividend Yield | 1.03% |
| Dividend Growth (YoY) | 10.31% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 34.35% |
| Buyback Yield | 0.48% |
| Shareholder Yield | 1.51% |
| Earnings Yield | 2.96% |
| FCF Yield | 3.83% |
Dividend DetailsAnalyst Forecast
The average price target for STERIS is $268.71, which is 10.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $268.71 |
| Price Target Difference | 10.21% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 6.79% |
| EPS Growth Forecast (5Y) | 16.58% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |
